Strategy, formerly known as MicroStrategy, has successfully completed a massive capital raise, securing $2.5 billion through preferred stock issuance - five times the originally planned $500 million.

Lassonde Industries Inc. (TSX: LAS.A) ("Lassonde" or the "Corporation") is pleased to announce that it will host a conference call to discuss its financial results for the second quarter of 2025 on ...

Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that through a separate ...

HCA Healthcare has delivered impressive second-quarter results that exceeded analyst expectations, with revenue climbing 6.4% to $18.61 billion, surpassing the projected $18.50 billion. The company's ...

CSX Corporation has become a focal point of merger speculation as industry consolidation gains momentum in the U.S. railroad sector. The company's stock is attracting investor attention following ...

RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers and digital ...

SIMPPLE Ltd. (NASDAQ: SPPL) (“SIMPPLE” or “the Company”), a leading technology provider and innovator in the facilities management (FM) sector, today announced that it has received notice from The ...

The European Commission has granted approval for Bayer's cancer medication Nubeqa to be used in treating metastatic hormone-sensitive prostate cancer, marking a significant milestone for the ...

Harmony Biosciences Holdings-Aktie: Kaufen oder verkaufen?! Neue Harmony Biosciences Holdings-Analyse vom 26. Juli liefert die Antwort: ...

Die Aktie des Prozessfinanzierers Burford Capital zeigt ein gespaltenes Bild: Während das Unternehmen erst kürzlich eine überzeichnete Anleiheemission abschließen konnte, kämpft der Kurs mit ...

CoinShares setzt mit der MiCA-Autorisierung ein klares Zeichen – als erster regulierter Vermögensverwalter Kontinentaleuropas verfügt das Unternehmen nun über eine einzigartige Dreifach-Lizenzierung.

Die Fusion von Starrag und Tornos entpuppt sich als Fehlstart: Im ersten Halbjahr 2025 stürzte die StarragTornos Group tief in die roten Zahlen. Ein Nettoverlust von 9,1 Millionen Franken markiert ...